Thus, it is worth exploring the modulation of the abnormal activity of NCX isoforms, which are selectively expressed in cancer cells, to disrupt intracellular Ca2+ balance and potentially hinder the progression of glioblastoma (GBM). The gene discussed is TLX2; the disease is cancer.